Cesamet and Anxiety aggravated - a phase IV clinical study of FDA data

Summary:

Anxiety aggravated is reported as a side effect among people who take Cesamet (nabilone), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Lyrica, and have Pain.

The phase IV clinical study analyzes which people have Anxiety aggravated when taking Cesamet. It is created by eHealthMe based on reports of 502 people who have side effects when taking Cesamet from the FDA, and is updated regularly.

What is Cesamet?

Cesamet has active ingredients of nabilone. It is often used in fibromyalgia. eHealthMe is studying from 548 Cesamet users. Check the latest studies of Cesamet.

What is Anxiety aggravated?

Anxiety aggravated is found to be associated with 2,804 drugs and 1,035 conditions by eHealthMe. Check the latest studies of Anxiety aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

502 people reported to have side effects when taking Cesamet.
Among them, 40 people (7.97%) have Anxiety aggravated.

Among these 40 people:

How long have people been on Cesamet when they have Anxiety aggravated? *

What is the gender of people who have Anxiety aggravated when taking Cesamet? *

female: 91.89 %
male: 8.11 %

What is the age of people who have Anxiety aggravated when taking Cesamet? *

What are other drugs people take besides Cesamet? *

What are other side effects people have besides Anxiety aggravated? *

Dizziness: 20 people, 50.00%
Fever: 16 people, 40.00%
Nausea And Vomiting: 15 people, 37.50%
Pain: 14 people, 35.00%
Malaise (a feeling of general discomfort or uneasiness): 14 people, 35.00%
Nasopharyngitis (inflammation of the nasopharynx): 14 people, 35.00%
Pneumonia: 14 people, 35.00%
Insomnia (sleeplessness): 13 people, 32.50%
Headache (pain in head): 13 people, 32.50%
Drug Intolerance (drug sensitivity): 11 people, 27.50%

What are the existing conditions these people have? *

Pain: 15 people, 37.50%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 30.00%
Drowsiness: 6 people, 15.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 15.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 15.00%
Back Pain: 5 people, 12.50%
Depression: 4 people, 10.00%
High Blood Pressure: 3 people, 7.50%
Muscle Spasms (muscle contraction): 3 people, 7.50%
Insomnia (sleeplessness): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cesamet and have Anxiety aggravated?

- Check whether Anxiety aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cesamet:

Cesamet (548 reports)

Browse all side effects of Cesamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anxiety aggravated:

Anxiety aggravated (2,804 drugs)

Browse all the conditions that are associated with Anxiety aggravated:

Anxiety aggravated (1,035 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nabilone (the active ingredients of Cesamet) and Cesamet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.